cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Immunic Inc
4 own
4 watching
Current Price
$2.87
$0.3
(11.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
87.72M
52-Week High
52-Week High
14.5
52-Week Low
52-Week Low
1.11
Average Volume
Average Volume
1.29M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization87.72M
icon52-Week High14.5
icon52-Week Low1.11
iconAverage Volume1.29M
iconDividend Yield--
iconP/E Ratio--
What does the Immunic Inc do?
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Read More
How much money does Immunic Inc make?
News & Events about Immunic Inc.
Ticker Report
1day ago
Immunic, Inc. (NASDAQ:IMUX Get Rating) Investment analysts at Wedbush issued their FY2027 earnings estimates for Immunic in a research note issued to investors on Tuesday, January 31st. Wedbush analyst L. Moussatos expects that the company will post earnings per share of ($1.62) for ...
PR Newswire
2 months ago
Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? Thinking about buying stock in Macy's, Immunic, LexinFintech, Provention Bio, or Clearside Biomedical? PR Newswire NEW YORK, Nov. 17, 2022 NEW YORK, Nov. 17, 2022 /PRNewswire...
Ticker Report
3 months ago
SVB Leerink cut shares of Immunic (NASDAQ:IMUX Get Rating) from an outperform rating to a market perform rating in a research report report published on Friday, MarketBeat reports. SVB Leerink currently has $5.00 price target on the stock. A number of other analysts have also commented on ...
PR Newswire
3 months ago
Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic? Thinking about buying stock in Myovant Sciences, Sellas Life Sciences, Borr Drilling, Mullen Automotive, or Immunic? PR Newswire NEW YORK, Oct. 24, 2022 NEW YORK, Oct. 24, 2022...
PR Newswire
3 months ago
Thinking about buying stock in T2 Biosystems, WISeKey, Immunic, Meta Materials, or Applied DNA Sciences? Thinking about buying stock in T2 Biosystems, WISeKey, Immunic, Meta Materials, or Applied DNA Sciences? PR Newswire NEW YORK, Oct. 13, 2022 NEW YORK, Oct. 13, 2022 /PRNewswire...
Frequently Asked Questions
Frequently Asked Questions
What is Immunic Inc share price today?
plus_minus_icon
Can Indians buy Immunic Inc shares?
plus_minus_icon
How can I buy Immunic Inc shares from India?
plus_minus_icon
Can Fractional shares of Immunic Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Immunic Inc stocks?
plus_minus_icon
What is today’s traded volume of Immunic Inc?
plus_minus_icon
What is today’s market capitalisation of Immunic Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Immunic Inc?
plus_minus_icon
What percentage is Immunic Inc down from its 52-Week High?
plus_minus_icon
What percentage is Immunic Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.87
$0.3
(11.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00